Yüklüyor......
Subcutaneous to Intravenous Prostacyclin Analogue Transition in Pulmonary Hypertension
INTRODUCTION: Prostacyclin analogues are FDA-approved therapies for the treatment of Pulmonary Arterial Hypertension (PAH) and can be administered by inhalational, intravenous (IV) or subcutaneous (SQ) routes. Since there is limited data to guide the transition between SQ to IV prostacyclin analogue...
Kaydedildi:
| Yayımlandı: | J Cardiovasc Pharmacol |
|---|---|
| Asıl Yazarlar: | , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2014
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4662283/ https://ncbi.nlm.nih.gov/pubmed/24084219 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/FJC.0000000000000018 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|